Molecular design using the minireceptor concept

Journal of Chemical Information and Computer Sciences

Volumn 37, Issue 4, 1997, Pages 812-818

  Jansen, Johanna M ^a,e   Koehler, Konrad F ^b   Hedberg, Martin H ^a   Johansson, Anette M ^a   Hacksell, Uli ^a   Nordvall, Gunnar ^c   Snyder, James P ^d  

^a UPPSALA UNIVERSITY   (Sweden)

^b Karo Bio   (Sweden)

^c Astra Arcus AB   (Sweden)

^d EMORY UNIVERSITY   (United States)

^e ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CELL SURFACE RECEPTOR; LIGAND; PACLITAXEL; SEROTONIN 1 RECEPTOR; SEROTONIN RECEPTOR;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG DESIGN; METABOLISM; PROTEIN CONFORMATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BINDING SITES; DRUG DESIGN; LIGANDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; PACLITAXEL; PROTEIN CONFORMATION; RECEPTORS, CELL SURFACE; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1;

EID: 0031178438     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci960110i     Document Type: Article

References (44)

1. Greer. J.: Erickson. J. W.; Baldwin. J. J.: Varneyk, M. D. Application of three-dimensional structures of protein target molecules in structure-based drug design. J. Med. Chem. 1994, 37, 1035-1054.
2. Fesik. S. W. NMR studies of molecular complexes as a tool in drug design. J. Med. Chem. 1991, 34, 2937-2945.
3. Hibert, M. F.; Trumpp-Kallmeyer. S.; Bruinvels. A.; Hoflack, J. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. Mol. Pharmacol. 1991, 40, 8-15.
4. Trumpp-Kallmeyer, S.; Hoflack, J.; Bruinvels, A.; Hibert, M. Modeling of G-protein-coupled receptors: Application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. J. Med. Chem. 1992, 35, 3448-3462.
5. Humblet, C.; Mirzadegan, T. Three-dimensional models of G-protein coupled receptors. Annu. Rep. Med. Chem. 1992, 27, 291-300.
6. Marshall, G. R.; Barry, C. D.; Bosshard, H. E., Dammkoehler, R. A.; Dunn. D. A. The conformational parameter in drug design: The Active Analog Approach. In Computer-Assisted Drug Design, American Chemical Society Symposium: Olson, E. C., Christofersen, R. E., Eds.; American Chemical Society: Washington, 1979; Vol. 112, pp 205-226.
7. Vedani, A.; Zbinden, P.; Snyder, J. P. Pseudo-receptor modeling: A new concept for the three-dimensional construction of receptor binding sites. J. Rec. Res. 1993, 13, 163-177.
8. Snyder, J. P.; Rao, S. N.; Koehler, K. F.; Vedani, A. Minireceptors and pseudoreceptors. In 3D QSAR in drug design; Kubinyi, H., Ed.; Escom Science Publishers B.V.: Leiden. The Netherlands 1993; pp 336-354.
9. Vedani, A.; Zbinden, P.; Snyder, J. P.; Greenidge, P. A. Pseudoreceptor modeling: The construction of three-dimensional receptor surrogates. J. Am. Chem. Soc. 1995, 117, 4987-4994.
10. Lewis, R. A.; Leach, A. R. Current methods for site-directed structure generation. J. Comp.-Aided Mol. Design 1994, 8, 467-475.
11. Waszkowycz, B.; Clark, D. E.; Frenkel, D.; Li, J.; Murray, C. W.; Robson, B.; Westhead, D. R. PRO LIGAND: An approach to de novo molecular design. 2. Design of novel molecules from molecular field analysis (MFA) models and pharmacophores. J. Med. Chem. 1994, 37, 3994-4002.
12. Martin, Y. C. 3D Database searching in drug design. J. Med. Chem. 1992, 35, 2145-2154.
13. Humblet, C.; Dunbar, J. B. 3D Database searching and docking strategies. Annu. Rep. Med. Chem. 1993, 28, 275-284.
14. Bures, M. G.; Martin, Y. C.; Willen, P. Searching techniques for databases of three-dimensional chemical structures. Topics Stereo-chemistry 1994, 21, 467-511.
15. Jansen, J. M.; Copinga, S.: Gruppen, G.; Molinari, E. J.; Dubocovich, M. L.; Grol, C. J. The high affinity melatonin binding site probed with conformationally restricted ligands I: Pharmacophore and minireceptor models. Bioorg. Med. Chem. 1996, 4, 1321-1332.
16. SIAT Biographies Laboratory, Missionsstrasse 60, CH-4055 Basel, Switzerland.
17. Vedani, A.; Huhta, D. W. A new force field for modeling metalloproteins. J. Am. Chem. Soc. 1990, 112, 4759-4767.
18. Wani, M. C.; Taylor, H. L.; Wall, M. E.; Coggon, P.; McPhail, A. T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia, J. Am. Chem. Soc. 1971, 93, 2325-2327.
19. Kingston, D. G. I. The chemistry of taxol. Pharmac. Ther. 1992, 52, 1-34.
20. Guénard, D.; Guéritte-Voegelein, F.; Potier, P. Taxol and Taxotere: Discovery, Chemistry, and Structure-Activity Relationships. Acc. Chem. Res. 1993, 26, 160-167.
21. Suffness, M. Taxol: From discovery to therapeutic use. Annu. Rep. Med. Chem. 1993, 28, 305-314.
22. Kingston, D. G. I. Taxol: The chemistry and Structure-Activity Relationships of a novel anticancer agent. Trends Biotech. 1994, 12, 222-227.
23. Schiff, P. B.; Fant, J.; Horwitz, S. B. Promotion of microtubule assembly in vitro by taxol. Nature 1979, 277, 665-667.
24. Schiff, P. B.; Horwitz, S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 1561-1565.
25. Horwitz, S. B. Mechanism of action of taxol. Trends Pharm. Sci. 1992, 13, 134-136.
26. Swindell, C. S.; Heerding, J. M.; Krauss, N. E.; Horwitz, S. B;. Rao, S.; Ringel, I. Characterization of two taxol photoaffinity analogues bearing azide and benzophenone-related photoreactive substituents in the A-ring side chain. J. Med. Chem. 1994, 37, 1446-1449.
27. Rao, S.; Krauss, N. E.; Heerding, J. M.; Swindell, C. S.; Ringel, I.; Orr, G. A.; Horwitz, S. B. 3′-(p-Azidobenzamido)taxol photolabels the N-terminal 31 amino acids of β-tubulin. J. Biol. Chem. 1994, 269, 3132-3134.
28. Dasgupta, D.; Park, H.; Harriman, G. C. B.; Georg, G. I.; Himes, R. H. Synthesis of a photoaffinity taxol analogue and its use in labeling tubulin. J. Med. Chem. 1994, 37, 2976-2980.
29. Dubois, J.; Guénard, D.; Gueritte-Voegelein, F.; Guedira, N.; Potier, P.; Gillet, B.; Beloeil, J.-C. Conformation of taxotere and analogues determined by NMR spectroscopy and molecular modeling studies. Tetrahedron 1993, 49, 6533-6544.
30. Williams, H. J.; Scott, A. I.; Dieden, R. A.; Swindell, C. S.; Chirlian, L. E.; Francl, M. M.; Heerding, J. M.; Krauss, N. E. NMR and molecular modeling study of the conformations of taxol and of its side chain methylester in aqueous and non-aqueous solution. Tetrahedron 1993, 49, 6545-6560.
31. Williams, H. J.; Scott, A. I.; Dieden, R. A.; Swindell, C. S.; Chirlian, L. E.; Francl, M. M.; Heerding, J. M.; Krauss, N. E. NMR and molecular modeling study of active and inactive taxol analogues in aqueous and nonaqueous solution. Can. J. Chem. 1994, 72, 252-260.
32. Houslay, M. D. G-protein linked receptors: A family probed by molecular cloning and mutagenesis procedures. Clin. Endocrinol. 1992, 36, 525-534.
33. Savarese, T. M.; Fraser, C. M. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem. J. 1992, 283, 1-19.
34. Henderson, R.; Baldwin, J. M.; Ceska, T. A.; Zemlin, F.; Beckmann, E.; Downing, K.H. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J. Mol. Biol 1990, 213, 899-929.
35. Nordvall, G.; Hacksell, U. Binding-site modeling of the muscarinic m1 receptor: A combination of homology based and indirect approaches. J. Med. Chem. 1993, 36, 967-976.
36. 3 receptors. Mol. Pharmacol. 1994, 46, 299-312.
37. Hamon, M. Neuropharmacology of anxiety: Perspectives and prospects. Trends Pharmacol. Sci. 1994, 15. 36-39.
38. Newman, M. E.; Lerer, B.; Shapira, B. 5-HT-1A receptor-mediated effects of antidepressants. Prog. Neuropsychopharmacol. Biol. Psychiat. 1993, 17, 1-19.
39. 1A receptor interactions. J. Med. Chem. 1995, 38, 647-658.
40. 1A receptor interactions. J. Med. Chem. 1996, 39, 3491-3502.
41. 1A receptor interactions. J. Med. Chem. 1996, 39, 3503-3513.
42. Kern, P.; Rognan, D.; Folkers, G. MD simulations in pseudo-particle fluids: Applications to active-site protein complexes. Quant Struct.-Act. Relat. 1995, 14, 229-241.
43. Kern, P.; Brunne, R. M.; van Gunsteren, W. G.; Folkers, G. A pseudoparticle approach for studying protein-ligand models truncated to their active sites. Biopolymers 1996, 38, 619-637.
44. SYBYL Molecular Modeling Software, version 6.22; Tripos, Inc.: 1699 S. Hanley Rd, St. Louis, MO 63144-2913.